6th Jul 2020 08:25
(Alliance News) - Chepstow, Wales-based medical device company Creo Medical Group PLC on Monday named Non-Executive Director David Woods as chief commercial officer, effective from August 1.
The company said that Woods' operating experience, market understanding and proven track record of achievement will hold them in good stead as the company moves from early clinical adoption to global commercialisation expansion.
Woods will be based in the US.
Creo CEO Craig Gulliford said: "Dave brings with him a wealth of experience in the med-tech sector having been a key driver of the Pentax Medical Americas team for more than 20 years."
Creo shares were up 0.3% at 209.66 pence on Monday morning in London.
By Greg Roxburgh; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Creo Medical